4CMenB tied to modest gonorrhea protection in real-world study - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

4CMenB tied to modest gonorrhea protection in real-world study

The 38.4% reduction in gonorrhea risk “could translate into preventing a substantial number of infections and complications.”

  • By

  • Julia Cipriano, MS, CMPP

  • September 9, 2026

  • 4 min

Share

Original Source(s)

4CMenB tied to modest gonorrhea protection in real-world study

  • by Julia Cipriano, MS, CMPP

  • September 9, 2026

Related Content

Immunization Awareness Month: How RTs Help Protect Patients

Adjuvanted and high-dose influenza vaccines had comparable effectiveness against test-confirmed influenza outcomes including hospitalizations in overall and high-risk older adults in the 2022–2023 and 2023–2024 seasons

Age-specific hospitalization dynamics during a measles outbreak in Nyanza District, Southern Province, Rwanda, 2026: A survival analysis with implications for clinical management